Epicore Biosystems
Cambridge
About Epicore Biosystems
Epicore Biosystems develops a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance ,and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Dr. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Bioelectronics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $41.9M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: epicorebiosystems.com
- Phone: +1 857-529-7776
Industries & Categories
Health Care, Medical Device, Personal Health, Wearables, Wellness
Social Profiles
Canonical: https://fsome.com/organization/epicore-biosystems-98769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.